Amino acid residues involved in the interaction of acetylcholinesterase and butyrylcholinesterase with the carbamates Ro 02-0683 and bambuterol, and with terbutaline.
In order to identify amino acids involved in the interaction of acetylcholinesterase (AChE; EC 3.1.1.7) and butyrylcholinesterase (BChE; EC 3.1.1.8) with carbamates, the time course of inhibition of the recombinant mouse enzymes BChE wild-type (w.t.), AChE w.t. and of 11 site-directed AChE mutants by Ro 02-0683 and bambuterol was studied. In addition, the reversible inhibition of cholinesterases by terbutaline, the leaving group of bambuterol, was studied. The bimolecular rate constant of AChE w.t. inhibition was 6.8 times smaller by Ro 02-0683 and 16000 times smaller by bambuterol than that of BChE w.t. The two carbamates were equipotent BChE inhibitors. Replacement of tyrosine-337 in AChE with alanine (resembling the choline binding site of BChE) resulted in 630 times faster inhibition by bambuterol. The same replacement decreased the inhibition by Ro 02-0683 ten times. The difference in size of the choline binding site in the two w.t. enzymes appeared critical for the selectivity of bambuterol and terbutaline binding. Removal of the charge with the mutation D74N caused a reduction in the reaction rate constants for Ro 02-0683 and bambuterol. Substitution of tyrosine-124 with glutamine in the AChE peripheral site significantly increased the inhibition rate for both carbamates. Substitution of phenylalanine-297 with alanine in the AChE acyl pocket decreased the inhibition rate by Ro 02-0683. Computational docking of carbamates provided plausible orientations of the inhibitors inside the active site gorge of mouse AChE and human BChE, thus substantiating involvement of amino acid residues in the enzyme active sites critical for the carbamate binding as derived from kinetic studies.
Kovarik
Z
Z
Institute for Medical Research and Occupational Health, Ksaverska c. 2, P.O. Box 291, HR-10001, Zagreb, Croatia.
Radić
Z
Z
Grgas
B
B
Skrinjarić-Spoljar
M
M
Reiner
E
E
Simeon-Rudolf
V
V
D000110:Acetylcholinesterase / Q000737:chemistry* / Q000235:genetics; D000596:Amino Acids / Q000737:chemistry*; D000818:Animals; D001665:Binding Sites; D002091:Butyrylcholinesterase; D002219:Carbamates / Q000494:pharmacology*; D002800:Cholinesterase Inhibitors / Q000494:pharmacology*; D006801:Humans; D007532:Isoleucine / Q000737:chemistry; D007700:Kinetics; D051379:Mice; D008958:Models, Molecular; D016297:Mutagenesis, Site-Directed; D009154:Mutation; D010649:Phenylalanine / Q000737:chemistry; D011487:Protein Conformation; D000644:Quaternary Ammonium Compounds / Q000494:pharmacology*; D013726:Terbutaline / Q000031:analogs & derivatives* / Q000494:pharmacology*
D000596:Amino Acids; D002219:Carbamates; D002800:Cholinesterase Inhibitors; D000644:Quaternary Ammonium Compounds; D007532:Isoleucine; C006266:Ro 20683; D010649:Phenylalanine; D000110:Acetylcholinesterase; D002091:Butyrylcholinesterase; D013726:Terbutaline; C047766:bambuterol